Immediate Impact

51 standout
Sub-graph 1 of 25

Citing Papers

Emerging nitric oxide gas‐assisted cancer photothermal treatment
2024 Standout
Therapeutic advances in rheumatoid arthritis
2024 Standout
5 intermediate papers

Works of Andrew Tracey being referenced

Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer.
2021
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
2008

Author Peers

Author Last Decade Papers Cites
Andrew Tracey 53 76 138 190 99 25 439
Jill Allbritton 11 95 169 280 45 18 495
Cumhur İbrahim Başsorgun 76 87 180 199 34 41 452
Qingran Yan 48 43 70 132 28 29 431
Andres Chiesa‐Vottero 37 177 87 60 64 23 508
Aikaterini Zioga 76 16 122 99 117 22 413
Ashraf M. Hassanein 68 77 53 59 224 27 508
Yehudith Ben‐Arieh 121 103 136 51 86 29 435
Paola Adele Lonati 41 41 156 174 68 20 453
Eléna Foïs 71 85 132 72 58 16 496
N. Hunzelmann 58 28 297 117 176 25 511

All Works

Loading papers...

Rankless by CCL
2026